Učitavanje...
Bioavailability of a dexlansoprazole delayed-release orally disintegrating tablet: effects of food and mode of administration
BACKGROUND: Dexlansoprazole is a proton pump inhibitor (PPI) approved for use in dual delayed-release capsule and orally disintegrating tablet (ODT) formulations. AIM: To assess effects of food, water, and route of administration on the bioavailability of dexlansoprazole 30-mg ODT. METHODS: Two sepa...
Spremljeno u:
| Izdano u: | Clin Exp Gastroenterol |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5323062/ https://ncbi.nlm.nih.gov/pubmed/28255251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S121129 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|